
<DOC>
<DOCNO>
WSJ900907-0023
</DOCNO>
<DOCID>
900907-0023.
</DOCID>
<HL>
   Technology Brief -- Cambridge BioScience Corp.:
   Investors Ratify Acquisition
   By Biotech Research Labs
</HL>
<DATE>
09/07/90
</DATE>
<SO>
WALL STREET JOURNAL (J), NO PAGE CITATION
</SO>
<CO>
   CBCX BTRL WNEWS
</CO>
<IN>
TENDER OFFERS, MERGERS, ACQUISITIONS (TNM)
MEDICAL AND BIOTECHNOLOGY (MTC)
</IN>
<LP>
   Cambridge BioScience Corp. said its shareholders ratified
the acquisition of the company by Biotech Research
Laboratories Inc. The shareholders also approved the change
of the company name to Cambridge Biotech Corp.
   Cambridge BioScience president Patrick J. Leonard will
remain as president and chief executive officer of the new
concern.
</LP>
<TEXT>
   Anthony C. Nicholls, president and a director of Biotech
Research of Rockville, Md., will become executive vice
president of Cambridge Biotech.
   The acquisition, already approved by Biotech Research
shareholders, is expected to close by next week. Cambridge
BioScience, Worcester, Mass., said the new company's board
will consist of its current board members and four additional
directors from Biotech Research: Thomas M. Li, W. Samuel
Nisbet, Thomas T. Taylor and Douglas Yee.
   Cambridge BioScience and Biotech Research are
biotechnology concerns.
</TEXT>
</DOC>